SEARCH RESULTS

1377 RESULTS

Spying on α-Synuclein Inclusions: PET Tracers Inch Closer to Success

CONFERENCE COVERAGE 2023-08-04 Conference Coverage PET tracers that illuminate α-synuclein in the brain have been hard to come by, but scientists may be getting closer. According to a study published August 3 in Cell, an 18F- tracer developed at Emory University, Atlanta, binds to α-sy

Cohort LEADS Toward Better Understanding of Sporadic Early Onset AD

CONFERENCE COVERAGE 2023-08-04 Conference Coverage When people think of early onset Alzheimer’s disease (EOAD), autosomal-dominant mutations in the APP or presenilin genes come to mind. But these account for fewer than 15 percent of EOAD cases. For the remainder, the Longitudinal Early

CSF MTBR-tau-243 Tracks Tangles, Plummets in Response to Antibody

CONFERENCE COVERAGE 2023-08-01 Conference Coverage More than a decade before memory loss, fragments of phospho-tau start to rise in biofluids. These biomarkers, particularly p-tau217, have proven to be exquisite detectors of amyloid, but they plateau once symptoms surface and don’t tra

Give BACE Inhibitors a Second Chance?

CONFERENCE COVERAGE 2023-07-29 Conference Coverage Scientists once hoped that blocking β-secretase would slow or prevent Alzheimer’s disease. Then came the rude awakening. The inhibitors caused the very thing they were supposed to prevent—cognitive decline. Enthusiasm tanked. Pharmaceu

Donanemab Data Anchors Upbeat AAIC

CONFERENCE COVERAGE 2023-07-28 Conference Coverage Change was in the air at the Alzheimer’s Association International Conference, held July 16-20 in Amsterdam. With the first treatment in 20 years having just earned traditional approval from the U.S. Food and Drug Administration, anoth

Long COVID and Dementia: The Link Is Still Elusive

CONFERENCE COVERAGE 2023-05-05 Conference Coverage With the emergence of COVID-19 three years in the past, the lingering neurological effects after initial illness remain nebulous. At the recent International Conference on Alzheimer’s and Parkinson’s Diseases in Gothenburg, Sweden, sci

New Arrows Aimed at Tau: Single-Domain Antibody, Peptibody, Vaccine

CONFERENCE COVERAGE 2023-05-03 Conference Coverage Tau pathology is proving a tough nut to crack, with most antibodies directed against it posting negative results in clinical trials thus far. At the recent International Conference on Alzheimer’s and Parkinson’s Diseases in Gothenburg,

Dysregulated Lipid Metabolism Comes to the Fore at AD/PD

CONFERENCE COVERAGE 2023-04-27 Conference Coverage After years of languishing in obscurity, the topic of disruptions in the brain's lipid metabolism is moving center stage. The number of publications in this area is growing, and at the International Conference on Alzheimer’s and P

By Unleashing Microglial cGAS, Tau STINGs Neurons

CONFERENCE COVERAGE 2023-04-26 Conference Coverage Springing a leak is rarely good news, but when microglial mitochondria start oozing, it can be particularly bad in situations of tauopathy. So conclude scientists led by Li Gan and Sadaf Amin, Weill Cornell Medicine, New York, in the A

With Microglia, It Takes a Village to Connect the Dots

CONFERENCE COVERAGE 2023-04-25 Conference Coverage New data presented at the International Conference on Alzheimer’s and Parkinson’s Diseases, held March 28 to April 1 in Gothenburg, Sweden, further reinforced the field's growing recognition that microglia respond in myriad ways t

From Phagocytosis to Exophagy: Microglia's Digestive Tract Dissected

CONFERENCE COVERAGE 2023-04-25 Conference Coverage The scientific diet at this year’s International Conference on Alzheimer’s and Parkinson’s diseases, March 28 to April 1 in Gothenburg, was especially rich in news about the ins and outs of the microglial “gastrointestinal tract,” aka

Next Goals for Immunotherapy: Make It Safer, Less of a Hassle

CONFERENCE COVERAGE 2023-04-21 Conference Coverage Anti-amyloid immunotherapy has reached a milestone with the approval of two antibodies for clinical use; alas, the race is far from over. At the International Conference on Alzheimer’s and Parkinson’s Diseases, held March 28 to April 1

Synuclein Assay Passes the Sniff Test—What of Other Seeds?

CONFERENCE COVERAGE 2023-04-21 Conference Coverage Seed amplification assays, those PCR-like reactions for toxic misfolded proteins, are starting to look pretty good. In the May Lancet Neurology, scientists led by Andrew Siderowf, University of Pennsylvania, Philadelphia, and Luis Conc

TREM2 Protects the Brain From Herpes. The Virus Fights Back.

CONFERENCE COVERAGE 2023-04-20 Conference Coverage Retroviruses lurking in the human genome aren’t the only potential troublemakers in neurodegenerative diseases (see Part 5  of this series). Herpes simplex virus type 1 (HSV-1) integrates into the genome of trigeminal ganglia nerves, c

Current Filters

  • Conference Coverage x
  • TYPE: News x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE
TYPE OF NEWS
DISEASE
TOPIC
BIOMOLECULE